Introduction to Challenges In Drug Development For Als
Exploring Challenges In Drug Development For Als reveals several interesting facts. Jinsy Andrews, director of neuromuscular
Challenges In Drug Development For Als Comprehensive Overview
What will it take to ALS drug development MIT Sloan Professor Andrew Lo goes through the
Richard Bedlack, MD, PhD, from Duke University moderates the
Summary & Highlights for Challenges In Drug Development For Als
- Jeffrey Rothstein, director of the Robert Packard Center for
- ALS
- ... for
- Day 1 of the Philadelphia 2022 Virtual CRLI presentations concluded with Dr. Jinsy Andrews discussing "Trial
- Presented By: Mark Kiel, MD, PhD Speaker Biography: Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, ...
Stay tuned for more updates related to Challenges In Drug Development For Als.
